Home • News • Calixar raises €1 Million
This new round will enable the French biotech company to license-out its isolation technologies for complex therapeutic targets and viral antigens
Starting from native material or recombinant systems, we succeed with all types of membrane proteins: GPCRs, Ions Channels, Transporters, Receptors and Viral Proteins.
© 2020 Calixar. All rights reserved.